Why on earth MM will not make her stay lengthy on the compnay becasue she earns $400K pa with ample upper hand to lecture the SHs and with little no resistance and challenge from the SHs, regulators, and Govt. (custodian of tax payers)?
Her clear meesage to the holders - either stay invested or leave. If you leave or become non holders, then keep hanging on HC as KBWs to spread the sentiments befitting your experience and insights that are not going to reduce any cents from her $400K pa.
MM should not lecture people by taking infinite time for complete resutls analyses. She claiemd holy grail, cure, statistically significant, ... since 2018, but there should have been more momentum of interests among the new and existign holders abou the three results.
As a holder, I remind myself and need to remind myself time and again to keep being optimisitc becasue I took decision to invest in the company.
It is good to see non-holders spending heaps of time and writing their views to a greater extent for generating awareness.
This company should have gone into any sort of partnership on its COVID results to generate some income after spending 20+ years of its existence on tax payers and SHs' money. SHs lack strength, but Govt. dedicated teams should have brought MM et al. into accountability to tell the ceo - " how can you justify your pay and .... for giving nothing but making SHs keep waiting for non-tangible outcome?". The research MM et al. are getting done should be done in a non-commercial basis with Govt grants, and if tangible outcome were achieved, it woud be a spin-off ompany with at least a commercial product. Without a commercially depolyed product, any company like Bitron sucking SHs and Tax payers money year after year is germinating unfair and unethical exercise of their intellectual abilities. It would be fair and ethical, if Biotron under MM et al. sell the platform to a more competent organisation that has more resources and capability to flourish it faster and better.
Slow and steady wins the race, but slow and steady in Biotech can make other ambitious and agile organizations under fast and furious managment can topple a company like Biotron. If Biotron's management want to use Biotron to remain employed by hook or by crook by using the Ouzelum Bird principle and by taking the advantage of slow and steady wins the race principle tending to show that they are not genuinely and seriously willing to commercialise at least a product to keep contrubuting to the Australian Economy, then the stroy will keep getting unfolded with carrot dangling and with goalpost keep getting shifted .... We SHs and tax payers expect that Biotron this year will bring the results that can get Biotron acquired by a resourceful and capable organisation that can develop the products much better and faster and bring them to the patients without subterfuse and unethical and unfair delays.
Recent Webinar by the management (MM et al.) suggests that they are very much detached from professional communication to engage with takeholders. "Not a home run" ..... and not willing to be specifc in deadliens, ......, no specifc articulation of the commercialisation ( whereas on every R&D incentives, we are informed the R&D incentives will be used for commercialisation....),..... are not what the SHs and tax payers are after. SHs and Tax payers need to see the progress that can lead to at least one commercial product this year that can be expected from Biotron started by Peter Gage 20+ years ago despite controversy raised by his contemporaries.
After 20+ years and particularly the hypes (holy grail and cure) generated since 2018 by the current management, it high time the current management demonstrated their sense of ethics and fair commitments just by commercialising at least one product and/selling the technology to a resourceful and capable organisation that can develop the products much better and faster and bring them to the patients across the glove and share the revenue with the biotron from the licensing deal. If the current management is not capable to show any progress their year, the earlier the goverment take initiative to question the current management about the the commercial viability/rationale of the products being researched and developed, the earlier the govement can minimise the loss of SHs' and tax payers' money into drain. It is wastage of time, space, resources for a tree that is sheer unlikely bear fruit. We need fruit from a tree (Bioron) getting nurtured for 20+ years, otherwise, it is better to sell the tree for firewoods of BBQ or ....
I as a holder want to remind me and keep remdinging me that the Biotron management will be successful to bring at least a commercial product in market if they (Biotron management ) maintain professional practice and ethics. and integrity ....
GY would explain things much better, but he (probably he)/she may be upset for not finding what he was after during this quater.
Have a lovely weekend, everyone!
BIT Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held
